Drug Profile
HIV gp120 DNA vaccine - Chiron/PowderJect
Latest Information Update: 22 Dec 2000
Price :
$50
*
At a glance
- Originator Chiron Corporation; PowderJect Vaccines
- Class AIDS vaccines; Gene therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 22 Dec 2000 Discontinued-Preclinical for HIV-1 infections in USA (IM)
- 12 Aug 1997 Preclinical development for HIV-1 infections in USA (IM)